William Goolsbee
Non-Executive Director
Nanoscience and Nanotechnology
Antisense Therapeutics
Australia
Biography
Mr. Goolsbee was founder, Chairman and Chief Executive Officer of Horizon Medical Inc. from 1987 until its acquisition by a unit of UBS Private Equity in 2002. Mr Goolsbee was a founding Director of ImmunoTherapy Corporation in 1993, and became Chairman in 1995, a position he held until overseeing the successful acquisition of ImmunoTherapy by AVI Biopharma, Inc. (now Sarepta Therapeutics) in 1998. Mr. Goolsbee served as Chairman of privately held BMG Pharma LLC, a pharmaceutical company, from 2006 through 2011 and of Metrodora Therapeutics until 2015. Mr Goolsbee was until the end of 2016 a Director of Sarepta Therapeutics Inc.
Research Interest
Nanoscience and Nanotechnology
